NLRP3 and autosomal dominant polycystic kidney disease: It is interesting to speculate that if the NLRP3 inflammasome is targeted early, we may avoid the promotion of a benign tumor to malignancy or the onset of bilaterality and/or multifocality in patients with ADPKD.